Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial.
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial. Am J Med. 2016 Sep; 129(9):1002-5.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Aspirin
Double-Blind Method
Drug Therapy, Combination
Gastrointestinal Hemorrhage
Humans
Omeprazole
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Ticlopidine
Treatment Outcome
authors with profiles
Christopher Paul Cannon, M.D.
Deepak L. Bhatt, M.D.
Muthiah Vaduganathan, M.D.